PRIMA-1MET induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5 protein

Molecular Cancer

Volumn 8, Issue , 2009, Pages

  Stuber, György ^a   Flaberg, Emilie ^a   Petranyi, Gabor ^a,b   Ötvös, Rita ^a   Rökaeus, Nina ^a   Kashuba, Elena ^a   Wiman, Klas G ^a   Klein, George ^a   Szekely, Laszlo ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN 5; METHIONINE; MUTANT PROTEIN; PROTEIN P53; PROTEIN PRIMA 1; UNCLASSIFIED DRUG; 2 HYDROXYMETHYL 2 METHOXYMETHYLAZABICYCLO(2.2.2)OCTAN 3 ONE; 2-HYDROXYMETHYL-2-METHOXYMETHYLAZABICYCLO(2.2.2)OCTAN-3-ONE; CHAPERONE; EBNA 5 PROTEIN, EPSTEIN BARR VIRUS; EBNA-5 PROTEIN, EPSTEIN-BARR VIRUS; QUINUCLIDINE DERIVATIVE;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOBLAST; CELL NUCLEUS; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; PROTEIN TRANSPORT; TUMOR CELL; VIRUS CELL TRANSFORMATION; WILD TYPE; CELL CULTURE; METABOLISM; NUCLEOLUS; TUMOR CELL LINE;

HUMAN HERPESVIRUS 4;

CELL LINE, TUMOR; CELL NUCLEOLUS; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HUMANS; MOLECULAR CHAPERONES; QUINUCLIDINES; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 65349174611     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-8-23     Document Type: Article

References (34)

1. Kieff E Current perspectives on the molecular pathogenesis of virus-induced cancers in human immunodeficiency virus infection and acquired immunodeficiency syndrome J Natl Cancer Inst Monogr 1998, 7-14 9709295
2. Rickinson A Epstein-Barr virus Virus Res 2002, 82:109-113 11885937
3. Alfieri C Birkenbach M Kieff E Early events in Epstein-Barr virus infection of human B lymphocytes Virology 1991, 181:595-608 1849678
4. Sinclair AJ Palmero I Peters G Farrell PJ EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus Embo J 1994, 13:3321-3328 395229 8045261
5. Harada S Kieff E Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation J Virol 1997, 71:6611-6618 191939 9261383
6. Szekely L Pokrovskaja K Jiang WQ de The H Ringertz N Klein G The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies J Virol 1996, 70:2562-2568 190102 8642686
7. Jiang WQ Szekely L Wendel-Hansen V Ringertz N Klein G Rosen A Co-localization of the retinoblastoma protein and the Epstein-Barr virus-encoded nuclear antigen EBNA-5 Exp Cell Res 1991, 197:314-318 1659990
8. Szekely L Pokrovskaja K Jiang WQ Selivanova G Lowbeer M Ringertz N Wiman KG Klein G Resting B-cells, EBV-infected B-blasts and established lymphoblastoid cell lines differ in their Rb, p53 and EBNA-5 expression patterns Oncogene 1995, 10:1869-1874 7753563
9. Pokrovskaja K Mattsson K Kashuba E Klein G Szekely L Proteasome inhibitor induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5 J Gen Virol 2001, 82:345-358 11161273
10. Szekely L Jiang WQ Pokrovskaja K Wiman KG Klein G Ringertz N Reversible nucleolar translocation of Epstein-Barr virus-encoded EBNA-5 and hsp70 proteins after exposure to heat shock or cell density congestion J Gen Virol 1995, 76(Pt 10):2423-2432 7595346
11. Mattsson K Pokrovskaja K Kiss C Klein G Szekely L Proteins associated with the promyelocytic leukemia gene product (PML)-containing nuclear body move to the nucleolus upon inhibition of proteasome-dependent protein degradation Proc Natl Acad Sci USA 2001, 98:1012-1017 14700 11158586
12. Kashuba E Mattsson K Klein G Szekely L p14ARF induces the relocation of HDM2 and p53 to extranucleolar sites that are targeted by PML bodies and proteasomes Mol Cancer 2003, 2:18 153488 12685933
13. Kashuba E Mattsson K Pokrovskaja K Kiss C Protopopova M Ehlin-Henriksson B Klein G Szekely L EBV-encoded EBNA-5 associates with P14ARF in extranucleolar inclusions and prolongs the survival of P14ARF-expressing cells Int J Cancer 2003, 105:644-653 12740913
14. Szekely L Selivanova G Magnusson KP Klein G Wiman KG EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins Proc Natl Acad Sci USA 1993, 90:5455-5459 46739 8390666
15. Bykov VJ Issaeva N Shilov A Hultcrantz M Pugacheva E Chumakov P Bergman J Wiman KG Selivanova G Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound Nat Med 2002, 8:282-288 11875500
16. Bykov VJ Issaeva N Selivanova G Wiman KG Mutant p53-dependent growth suppression distinguishes PRIMA-1 from known anticancer drugs: A statistical analysis of information in the National Cancer Institute database Carcinogenesis 2002, 23:2011-2018 12507923
17. Bykov VJ Selivanova G Wiman KG Small molecules that reactivate mutant p53 Eur J Cancer 2003, 39:1828-1834 12932659
18. Rokaeus N Klein G Wiman KG Szekely L Mattsson K PRIMA-1(MET) induces nucleolar accumulation of mutant p53 and PML nuclear body-associated proteins Oncogene 2007, 26:982-992 16909106
19. Finke J Rowe M Kallin B Ernberg I Rosen A Dillner J Klein G Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines J Virol 1987, 61:3870-3878 256005 2824821
20. Rehman A Chahal MS Tang X Bruce JE Pommier Y Daoud SS Proteomic identification of heat shock protein 90 as a candidate target for p53 mutation reactivation by PRIMA-1 in breast cancer cells Breast Cancer Res 2005, 7:R765-774 1242148 16168122
21. Zylicz M King FW Wawrzynow A Hsp70 interactions with the p53 tumour suppressor protein Embo J 2001, 20:4634-4638 125613 11532927
22. Muller P Hrstka R Coomber D Lane DP Vojtesek B Chaperone-dependent stabilization and degradation of p53 mutants Oncogene 2008, 27(24):3371-83 18223694
23. Nylandsted J Rohde M Brand K Bastholm L Elling F Jaattela M Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2 Proc Natl Acad Sci USA 2000, 97:7871-7876 16637 10884417
24. Allan GJ Inman GJ Parker BD Rowe DT Farrell PJ Cell growth effects of Epstein-Barr virus leader protein J Gen Virol 1992, 73(Pt 6);1547-1551 1318948
25. Mannick JB Cohen JI Birkenbach M Marchini A Kieff E The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation J Virol 1991, 65:6826-6837 250776 1658376
26. Mannick JB Tong X Hemnes A Kieff E The Epstein-Barr virus nuclear antigen leader protein associates with hsp72/hsc73 J Virol 1995, 69:8169-8172 189776 7494344
27. Peng CW Zhao B Chen HC Chou ML Lai CY Lin SZ Hsu HY Kieff E Hsp72 up-regulates Epstein-Barr virus EBNALP coactivation with EBNA2 Blood 2007, 109:5447-5454 1890828 17341665
28. Wiman KG Restoration of Wild-Type p53 Function in Human Tumors: Strategies for Efficient Cancer Therapy Adv Cancer Res 2007, 97:321-338 17419952
29. Selivanova G Wiman KG Reactivation of mutant p53: Molecular mechanisms and therapeutic potential Oncogene 2007, 26:2243-2254 17401433
30. Wiman KG Strategies for therapeutic targeting of the p53 pathway in cancer Cell Death Differ 2006, 13:921-926 16557267
31. Bykov VJ Wiman KG Novel cancer therapy by reactivation of the p53 apoptosis pathway Ann Med 2003, 35:458-465 14649328
32. Charlot JF Nicolier M Pretet JL Mougin C Modulation of p53 transcriptional activity by PRIMA-1 and Pifithrin-alpha on staurosporine-induced apoptosis of wild-type and mutated p53 epithelial cells Apoptosis 2006, 11:813-827 16554962
33. Supiot S Zhao H Wiman K Hill RP Bristow RG PRIMA-1(met) radiosensitizes prostate cancer cells independent of their MTp53-status Radiother Oncol 2008, 86:407-411 18237796
34. Shi H Lambert J Hautefeuille A Bykov V Wiman K Hainaut P Caron de Fromentel C In vitro and in vivo cytotoxic effects of PRIMA-1 on Hepatocellular Carcinoma cells expressing mutant p53ser249 Carcinogenesis 2008, 29(7):1428-34 18048389